Addiction Medicine - Online Tool Educates MySpace Generation about Opioid Addiction
Nanotechnology - New treatment effective in counteracting cocaine-induced symptoms
Allergies - Collegium Pharmaceutical Provides Update on Development of its Nasal Inhaled Steroid for Allergic Rhinitis
Bacterial Conjunctivitis - Inspire Pharmaceuticals Launches AzaSite in the United States for Ocular Infections
Bioengineering - ADVENTRX Announces Fast Track Designation Granted By the FDA for CoFactor for the Treatment of Metastatic Colorectal Cancer
Bioengineering - BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
Bioengineering - EKR Therapeutics Achieves Key Growth Milestone with the Acquisition of Rights from Pacira Pharmaceuticals to DepoDur, a Novel Extended-Release Opioid Analgesic for Post Operative Pain
Bioengineering - Mylan Announces Final FDA Approval for Verapamil Hydrochloride Extended-Release Capsules (PM)
Bioengineering - Noted Drug Development Authority Dr. Hans Van Bronswijk Expands PAREXEL Consulting's European Practice
Bioengineering - TyRx Pharma, Inc., Announces the Hiring of Mark Citron as Vice President, Clinical and Regulatory Affairs
Biohazards - Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
Biological Warfare - SIGA Technologies Reports Second Quarter 2007 Results of Operations
Biological Warfare - SIGA Technologies to Present at the Noble Financial Small Cap Conference
Biotechnology Business - Antares Pharma Reports Second Quarter 2007 Financial and Operating Results
Biotechnology Business - APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection
Biotechnology Business - Positive Kuvan Pivotal Phase 3 Trial Results Published in the Lancet
Breast Cancer - BSD Medical Obtains Patent License for Primary Breast Cancer Treatment System from Duke University
Cancer - EMEA Recommends Orphan Drug Designation for PI-88
Cancer - Pro-Pharmaceuticals Announces ''Compassionate Use'' IND for DAVANAT to Treat Biliary Cancer Patient
Cancer - Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine (VNP40101M) in Elderly AML
Cancer Gene Therapy - Statement from the Cancer Cure Coalition: the Cancer Cure Coalition Protests the Federal Court's Ruling Against the Abigail Alliance
DNA Vaccines - Inovio Biomedical Partner Tripep Receives Approval to Initiate Phase I/II Study of Novel Vaccine for Hepatitis C Virus
Drug Development - Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Prandin
Drug Development - FDA Warns Consumers to Avoid Red Yeast Rice Products Promoted on Internet as Treatments for High Cholesterol
Drug Development - Joel Z. Melnick, MD Joins Cytochroma as Vice President, Clinical & Regulatory Affairs
Drug Development - Medicines Regulator cancels registration of anti inflammatory drug, Lumiracoxib (Prexige)
Drug Development - Sucampo Pharmaceuticals Reports Financial Results for the Second Quarter of 2007
Drug Development - Teva Announces Approval of Epirubicin Hydrochloride Injection
Emergency Preparedness - Ad-hoc-Announcement according to ? 15 WpHG Sanochemia Pharmazeutika AG - WKN 919963
Financing - Extend Health Raises $15 Million in Series B Funding
Friedreich Ataxia - European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera
Health Policy - Sen. Dave Durenberger Joins Health Fitness Corporation's Board of Directors
Heart Failure - GlaxoSmithKline Updates Prescribing Information for Avandia
HIV/AIDS - NEJM Direct-to-Consumer Ad Study Shows Drug Industry Incapable of Self- Regulation, Says AHF
Hypertension - FDA Grants Additional Six Months Marketing Exclusivity for the High Blood Pressure Medicine Diovan
Lice Infestation - Sciele Pharma Announces FDA Acceptance of NDA for Summers Laboratories' Head Lice Treatment
Lyme Disease - New Methods for Preventing Lyme Disease
Malaria - $7.8 Million in New USAID Grant to Senegal for Community Action Against Malaria Campaign